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Countries with no autochthonous measles run the risk 
of the virus being imported by travellers and transmit-
ted to unprotected citizens. In April 2012, two travel-
lers from Finland and one from Estonia were diagnosed 
with measles after returning from Phuket, Thailand. 
They were contagious on their return flights and sub-
sequently exposed several individuals, prompting 
extensive infection control measures. Two secondary 
cases were detected: one child who had received one 
vaccine dose and another who was fully vaccinated.
In April 2012, three people who had travelled from 
Finland contracted measles after their return from 
Phuket, Thailand. We describe here the measures 
taken for these three cases and the identification of 
secondary cases. 
Case 1 was an Estonian woman in her early 30s living 
in Finland, who may have received one dose of mea-
sles vaccine during childhood. She flew to Phuket on 
23 March and her symptoms started on 3 April. When 
flying back to Helsinki on 6 April, she had both a 
fever and a rash. The next day she was referred from 
a healthcare centre to Hospital A. It was only the fol-
lowing day (8 April), after she had been admitted to 
infectious diseases Hospital B, that measles was sus-
pected. The diagnosis was confirmed (positive serum 
IgM and detection of measles virus RNA by PCR from 
oral fluid, throat and urine samples) on 12 April. 
Case 2, an unvaccinated Finnish woman in her early 
40s, had no history of measles. She took the same 
flight to Phuket as Case 1 and developed fever on the 
morning of her return flight on 6 April. She was admit-
ted to Hospital C on 8 April. The next day, measles was 
suspected and she was transferred to infectious dis-
eases Hospital B. The diagnosis was confirmed (posi-
tive serum IgM and detection of measles virus RNA by 
PCR from oral fluid, throat and urine samples) on 12 
April. 
Case 3, an Estonian woman in her early 30s, may have 
received one dose of measles vaccine during childhood. 
Having arrived in Phuket on 19 March, she developed 
fever and began coughing and sneezing on the day of 
her flight home, 2 April. She then travelled by ferry 
from Helsinki to Tallinn, Estonia, and soon returned to 
her work as schoolteacher. Her symptoms persisted 
and she was first examined by a family doctor on 5 
April, then admitted to Hospital D and subsequently to 
infectious diseases Hospital E, where finally measles 
was suspected. The diagnosis was confirmed (positive 
serum IgM) seven days later, on 13 April.  
It is noteworthy that all three cases stayed at different 
hotels in Thailand and had no known contact with one 
another besides the flights taken by Cases 1 and 2. 
Background
Outbreaks of measles still occur repeatedly in Europe 
in many areas where vaccination coverage is not suf-
ficiently high [1,2]. In countries with high coverage, 
such as Finland (>95%) [3], the small proportion of 
unprotected citizens (unvaccinated or not having had 
the disease) are virtually at no risk of contracting the 
virus, as it has ceased to circulate among the popula-
tion. However, such individuals may get infected when 
travelling and, after their return, transmit the virus to 
others who are also unprotected, as has been seen in 
Finland (Table 1). Thus not even high vaccination cover-
age will prevent local clusters of the disease [3]. Once 
measles is suspected, infection control is urgently 
needed to prevent its potential spread. Notably, how-
ever, the suspicion of measles can be delayed in coun-
tries with no autochthonous measles, since clinicians 
may no longer recognise the disease. 
Control measures   
The national recommendations advise all travellers 
to check their vaccination status, including that for 
mumps-measles-rubella (MMR) vaccine before travel, 
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yet, our experience is that short-term travellers to 
Thailand, like our patients, seldom seek pre-travel 
advice.
In all three cases, once measles was suspected, the 
patients were immediately placed in isolation with air-
borne precautions. Doctors responsible for communi-
cable disease control in Finland and Estonia, and the 
National Institute for Health and Welfare in Finland 
were also informed about the cases. All three cases 
had all been contagious on their return flights, and 
had afterwards, in their home country, been in con-
tact with several individuals. Upon confirmation of 
the diagnoses of Cases 1 and 2 on 12 April, the doc-
tor in Hospital B, having first interviewed the patients, 
alerted Hospitals A and C, as well as the communicable 
diseases doctor responsible for all health centres, to 
begin contact tracing (Table 2). 
After receiving the flight number of Cases 1 and 2 on 
12 April, the National Institute for Health and Welfare 
contacted the travel agency responsible for the trip. 
The travel agency provided the telephone numbers 
and email addressed for all passengers. SMS (text) 
messages were sent on the same day alerting them 
to read their emails specifying the symptoms of mea-
sles. Should any passenger develop any of the symp-
toms, they were advised to call their health centres for 
guidance. Post-exposure prophylaxis (immunoglobulin 
or MMR vaccination) was no longer an issue as a week 
had passed since the flight.
On 12 April, the Finnish Early Warning and Response 
System (EWRS) team was notified about Case 3 in 
Estonia by the Estonian EWRS team, who also provided 
the flight number and all passengers were informed 
the same way as described above. A decision was 
made not to undertake contact tracing among ferry 
passengers.
In Finland, the National Institute for Health and Welfare 
sent emails to all healthcare districts informing them 
about the cases as well as the national guidelines [4] 
on 13 April.    In the two countries, a total of 772 persons 
were reached and 21 of them, mainly health profes-
sionals, were given post-exposure prophylaxis (Table 
2). Contact tracing revealed two secondary cases. The 
first, a 9-year-old pupil at the school in Estonia where 
Case 3 worked, had previously received one dose of 
MMR vaccine. The second, a fully vaccinated 13-year-
old in Finland, had taken the same flights as Cases 1 
and 2. The child’s symptoms started on 16 April, imply-
ing that he could have contracted the disease already 
in Thailand. 
The virus isolated from Cases 1 and 2 belonged to 
genotype D8, known to be circulating in Thailand 
(MeaNS, http://www.who-measles.org). 
Discussion 
In Finland, circulation of measles virus ceased in the 
mid-1990s [3]. All reported cases since 1996 have been 
laboratory confirmed, the source of infection has been 
traced and infection control measures taken [3] (Table 
1). Despite the relatively large number of travellers to 
and from Finland (annual average of 5 million and 6.4 
million, respectively) [3], measles cases have been 
rare, contracted mostly in other European countries 
(Table 1). In Thailand, despite the national immunisa-
tion programme, measles outbreaks still occur occa-
sionally in both rural and urban areas [5]. Over 100,000 
flights are taken by Finns to Thailand every year [6], 
yet only one measles case has been reported among 
travellers returning from Thailand, in 2008, before the 
cases reported here (Table 1). It is noteworthy that on 
14 May 2012, measles was reported also in a Russian 
traveller having recently returned from Thailand [7].
In the present instance, the diagnostic tests were 
delayed due to the Easter holidays and a misunder-
standing at the laboratory. Even if further transmission 
from the index cases had been blocked by isolat-
ing the patients, the time window for post-exposure 
prophylaxis proved too long for many contacts. Despite 
this, those who had not had measles or two doses of 
MMR vaccine were, of course, advised to ensure that 
their vaccination series were completed. Finns born 
between 1960 and 1975 have not always received the 
vaccines or had the disease; many healthcare workers 
table 1
Measles cases in Finland, January 1996–May 2012 (n=47) 
Year Number of casesa Country visited by index cases
1996 0 –
1997 0 –
1998 1 Brazil
1999 0 –
2000 2 Sweden (n=1), India (n=1)
2001 1 Papua New Guinea
2002 0 –
2003 0 –
2004 0 –
2005 1 Italy
2006 0 –
2007 0 –
2008 5 Thailand (n=1), Switzerland (n=1), England (n=3)
2009 2 Iraq (n=1), Italy(n=1)
2010 5 Senegal (n=1), Italy (n=1)
2011 27 France (n=3), Latvia/Sweden (n=1)
2012 3 Thailand (n=2)
a Index cases and secondary cases are included.
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table 2
Persons born after 1960a reached through contact tracing and post-exposure prophylaxis administered, Finland and Estonia, 
April 2012 (n=772) 
Site and group of individuals traced Number of persons traced
Number of persons vaccinated with 
two doses of MMR vaccine or measles 
verified /number of persons with 
information available
Post-exposure prophylaxis administered
Immunoglobulin MMR vaccine
Aircraft 1 290b,c NA 0 0
Aircraft 2 290b,c NA 0 0
Case 1 (in Finland)
Hospital A
Emergency unit patients 2 2/2 0 0
Radiology staff/patients 4 3/3 0 0
Healthcare staff 14 13/13 0 0
Healthcare centre staff/patients 16 8/12c 1 1
Hospital B
Healthcare staff 2 1/2 0 1
Family and friends 4 2/4c 0 0
Total 42 29/36c 1 2
Case 2 (in Finland)
Hospital C
Emergency unit patients 12 9/12 3 0
Patients on same ward 1 0/1 0 1
Radiology staff/patients 5 5/5 0 0
Visitors 2 1/2 1 0
Healthcare staff 31 18/31 0 13
Family and friends 6 6/6 0 0
Total 57 39/57 4 14
Case 3 (in Estonia)
Family practice
Personnel 2 1/2c 0 0
Other patients 3 2/3c 0 0
Ambulance staff 3 2/3c 0 0
Hospital D
Healthcare staff 5 2/5c 0 0
Hospital E
Healthcare staff 17 10/17c 0 0
Family and friends 3 2/3c 0 0
Colleagues at school 10 2/10c 0 0
Pupils at schoold 50 49/50c 0 0
Total 93 70/93c 0 0
Grand total 772 138/186c 5 16
MMR: mumps-measles-rubella; NA: not available.
a In Finland, most individuals born before 1960 have had measles and are therefore considered immune. 
b Includes passengers of all ages on board the plane. 
c Those considered susceptible, but only reached more than 72 hours after the exposure were (i) informed about the symptoms of measles, 
(ii) instructed to call their healthcare centre, should any symptoms occur, and (iii) instructed to ensure that their MMR vaccinations were 
complete. 
d Children aged 7–9 years vaccinated with one dose of MMR vaccine (second dose planned at the age of 13 years).
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may belong to this age group, which is reflected in the 
numbers of unprotected individuals among healthcare 
staff in Hospital C (Table 2).
It should be noted that one of the secondary cases was 
a child who had received two vaccine doses. It appears 
that the child had seroconverted earlier, since mea-
sles IgG antibody level was relatively high on 20 April, 
i.e. only four days after the onset of the symptoms. 
Measles has, although rarely, been described in vac-
cinees with earlier documented seroconversion [8-13]. 
On this occasion, the process of reaching the flight pas-
sengers ran exceptionally smoothly. The travel agency 
readily provided both telephone numbers and email 
addresses for all passengers on the two charter flights. 
Emails and SMS messages were swiftly arranged. 
Information about individuals with infectious measles 
on an aircraft usually arrives too late, and passenger 
lists are not easily available, as was the case with trav-
ellers who had travelled on the same ferry as Case 3. If 
so, a press release is the most efficient means of con-
tacting people. 
Travellers returning infected may occasionally sig-
nal ongoing outbreaks in their destination countries. 
International networks alert their members about 
cases in the various countries. When reporting our 
cases on the European Network for Tropical Medicine 
and Travel Health (TropNet) member site, we learned 
that no outbreaks of measles had been identified in 
Thailand as yet (Dr Jiri Beran, personal communication, 
26 April 2012). While both flights with the measles 
cases on board were destined for Finland, presumably 
flying mostly Finnish passengers, information on the 
flight carrying Case 3 relied entirely on the Estonian 
EWRS team reporting their case. This accentuates the 
importance of accurate surveillance and international 
networking as central tools for infection control.
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